Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Enzo Biochem Inc.
Headquarters: Farmingdale, NY, United States of America
Website: http://www.enzo.com
Year Founded: 1976
Status: Public
Industry Sector: HealthTechnology
CEO: Kara Cannon
Number Of Employees: 136
Enterprise Value: $4,166,280
PE Ratio: -1.05
Exchange/Ticker 1: NYSE:ENZ
Exchange/Ticker 2: N/A
Latest Market Cap: $24,084,500
BioCentury | Sep 7, 2023
Management Tracks
Biogen taps former Genentech exec Grogan as head of research
Plus: Arjona Ferreira named CMO at Organon, and updates from Convergent, Purespring, Nanobiotix, Enzo, FibroGen, Engitix and more
BioCentury | Oct 20, 2022
Management Tracks
5AM hires Anna Yaeger as head of public equities
Plus Scripps alum Maricich becomes Ashvattha CMO and updates from Alexion, Rewind, ExeVir and more
BioCentury | Mar 29, 2022
Management Tracks
Rangwala to be CMO at Karyopharm
Plus Jones becomes CFO at Sense, and updates from Enzo, Dice and more
BioCentury | Oct 19, 2021
Management Tracks
Carl June joins Bioheng’s SAB
Plus: Myriad, Kura, Ideaya, IASO, OncoCyte and more
BioCentury | Sep 23, 2021
Management Tracks
Vandebroek named CFO at Hyloris
Plus: Brooklyn ImmunoTherapeutics, Frazier, Renovacor, Rewind and more
BioCentury | Nov 5, 2019
Company News
Management tracks: Santhera, Acadia, Aeglea, Entrada, Kleo, Laboratory for Advanced Medicine, Imago, Glympse and Cognition
Items per page:
1 - 10 of 171